Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 55501-55550 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06105021
Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor
PHASE1/PHASE2Active, not recruiting
100 participants
Started: Mar 6, 2024 · Completed: Dec 31, 2029
5 conditions1 sponsor10 locations
NCT06728163
Impact of Virtual Reality (VR) and Music Intervention
NARecruiting
140 participants
Started: Mar 6, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06118736
GUIDed Growth of the Proximal Femur to Prevent Further Hip MigrAtion in CErebral Palsy Patients
NARecruiting
84 participants
Started: Mar 6, 2024 · Completed: Dec 31, 2030
2 conditions1 sponsor5 locations
NCT05977712
Circadian Rhythm and Other Factors in Memory Clinic Patients
N/ARecruiting
1,500 participants
Started: Mar 6, 2024 · Completed: Mar 31, 2042
1 condition3 sponsors2 locations
NCT06267521
The STRENGTHEN Study
NARecruiting
96 participants
Started: Mar 6, 2024 · Completed: Feb 28, 2026
2 conditions2 sponsors1 location
NCT06248814
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis
PHASE1Active, not recruiting
54 participants
Started: Mar 6, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor13 locations
NCT06280482
Nicotinamide Riboside (NR) to Treat Moyamoya-like Cerebrovascular Disease in Smooth Muscle Dysfunction Syndrome (SMDS)
PHASE1Recruiting
15 participants
Started: Mar 6, 2024 · Completed: Jul 25, 2027
1 condition1 sponsor1 location
NCT06195982
Ketones in Heart Failure With Reduced Ejection Fraction
PHASE2Enrolling by invitation
25 participants
Started: Mar 6, 2024 · Completed: Feb 28, 2027
1 condition4 sponsors1 location
NCT06206174
TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies
PHASE1/PHASE2Recruiting
30 participants
Started: Mar 6, 2024 · Completed: Feb 28, 2029
5 conditions2 sponsors1 location
NCT06305741
A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers
NARecruiting
60 participants
Started: Mar 5, 2024 · Completed: Mar 31, 2026
2 conditions1 sponsor7 locations
NCT05839535
Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA
PHASE2Recruiting
140 participants
Started: Mar 5, 2024 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT06288217
Non-invasive Trigeminal and Vagus Nerve Stimulation for Stroke Subjects With Chronic Upper Extremity Deficits
NARecruiting
25 participants
Started: Mar 5, 2024 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT06099366
Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children
PHASE2Recruiting
116 participants
Started: Mar 5, 2024 · Completed: Dec 31, 2033
1 condition9 sponsors9 locations
NCT06329050
The Effects of Losartan on Attention Control: An Eye-tracking Study
NARecruiting
80 participants
Started: Mar 5, 2024 · Completed: Jul 30, 2025
1 condition1 sponsor1 location
NCT06300606
Nociception Index Level (NOL) Perioperative Monitoring During Regional Anesthesia
N/ARecruiting
25 participants
Started: Mar 5, 2024 · Completed: Apr 15, 2024
3 conditions5 sponsors1 location
NCT06319911
AETOS Shoulder System
N/ARecruiting
220 participants
Started: Mar 5, 2024 · Completed: Aug 30, 2030
2 conditions1 sponsor5 locations
NCT05939934
Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal
NARecruiting
40 participants
Started: Mar 5, 2024 · Completed: Nov 30, 2025
2 conditions1 sponsor1 location
NCT06511128
Evaluation of the Depth of Anesthesia With 4-Channel EEG in Patients Undergoing Drug-Induced Sleep Endoscopy (DISE)
N/AActive, not recruiting
50 participants
Started: Mar 5, 2024 · Completed: May 30, 2025
1 condition1 sponsor1 location
NCT05689021
CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations
PHASE2Recruiting
30 participants
Started: Mar 5, 2024 · Completed: Sep 30, 2025
3 conditions1 sponsor3 locations
NCT06298773
Spatial Profile of Tumors
N/ANot yet recruiting
1,000 participants
Started: Mar 5, 2024 · Completed: Dec 30, 2028
1 condition1 sponsor1 location
NCT05568199
Udall Project 1 Aim 4
N/ARecruiting
100 participants
Started: Mar 5, 2024 · Completed: Jan 1, 2035
2 conditions1 sponsor1 location
NCT04838652
Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma
PHASE2Recruiting
29 participants
Started: Mar 5, 2024 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT05950594
IVIM & OLINK in Sarcoma
PHASE2Recruiting
145 participants
Started: Mar 5, 2024 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT06385951
Spatial Navigation for the Early Detection of Alzheimer's Disease.
NARecruiting
160 participants
Started: Mar 5, 2024 · Completed: Oct 1, 2028
3 conditions1 sponsor1 location
NCT06075745
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
PHASE2Recruiting
416 participants
Started: Mar 5, 2024 · Completed: Feb 28, 2028
1 condition1 sponsor18 locations
NCT06203912
Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma
PHASE1Recruiting
30 participants
Started: Mar 5, 2024 · Completed: Aug 31, 2025
2 conditions2 sponsors1 location
NCT06346262
Seizure Rescue Medication (RM) As Part of a Comprehensive Epilepsy Self-management Package of Care
PHASE4Recruiting
43 participants
Started: Mar 5, 2024 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT06242405
Effect of Different Frequencies of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients with ESLD
NARecruiting
92 participants
Started: Mar 5, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06256055
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
PHASE1Recruiting
24 participants
Started: Mar 5, 2024 · Completed: Apr 30, 2025
7 conditions2 sponsors1 location
NCT06138561
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
N/ARecruiting
180 participants
Started: Mar 5, 2024 · Completed: Jul 1, 2026
4 conditions3 sponsors1 location
NCT06772220
Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease
NARecruiting
150 participants
Started: Mar 5, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06249945
EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease
PHASE4Recruiting
150 participants
Started: Mar 5, 2024 · Completed: Dec 31, 2030
2 conditions2 sponsors2 locations
NCT06006013
Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer
PHASE2Active, not recruiting
21 participants
Started: Mar 5, 2024 · Completed: Dec 16, 2025
5 conditions2 sponsors2 locations
NCT06699381
Spinal Straightness, Posture And Balance, Physical Performance And Energy Consumption In Individuals With Stroke
N/ARecruiting
30 participants
Started: Mar 5, 2024 · Completed: Jul 5, 2025
3 conditions1 sponsor1 location
NCT06329063
Oral Vasopressin Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study
NARecruiting
80 participants
Started: Mar 5, 2024 · Completed: Jul 30, 2025
1 condition1 sponsor1 location
NCT05499663
Title: Leveraging Technology to Address Health Outcomes of Cancer Survivors
PHASE1/PHASE2Active, not recruiting
54 participants
Started: Mar 5, 2024 · Completed: Jul 31, 2028
3 conditions3 sponsors1 location
NCT06474156
MOTIV8 - Treatment Motivation in Forensic Youth Treatment
N/ARecruiting
16 participants
Started: Mar 5, 2024 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT06289439
Effect of Green Tea Supplementation in Older Adult Women
NARecruiting
120 participants
Started: Mar 5, 2024 · Completed: Apr 1, 2025
3 conditions3 sponsors1 location
NCT06031259
Extension Study of Idursulfase-IT Along With Elaprase in Children and Adults With Hunter Syndrome and Cognitive Impairment
PHASE2/PHASE3Active, not recruiting
6 participants
Started: Mar 5, 2024 · Completed: Jan 1, 2029
1 condition1 sponsor4 locations
NCT06286917
Initiation of Noninvasive Ventilation in ALS Patients With Chronic Respiratory Insufficiency
NARecruiting
120 participants
Started: Mar 5, 2024 · Completed: Dec 31, 2029
3 conditions1 sponsor1 location
NCT06183034
Acceptability and Feasibility of a Preoperative Very Low Calorie Diet Intervention on Surgical Weight Loss Outcomes (SAFETY)
NANot yet recruiting
30 participants
Started: Mar 5, 2024 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05728476
Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Diabetic Macular Edema
NARecruiting
102 participants
Started: Mar 5, 2024 · Completed: Sep 5, 2026
3 conditions1 sponsor1 location
NCT06094816
Forebrain Electroneutral Transporters in Salt-sensitive Hypertension: an MRI Study
NARecruiting
120 participants
Started: Mar 5, 2024 · Completed: Jul 31, 2028
1 condition2 sponsors1 location
NCT05997979
Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children
PHASE3Recruiting
46 participants
Started: Mar 5, 2024 · Completed: Apr 5, 2026
2 conditions1 sponsor10 locations
NCT06462287
EFFECT OF A SUBSTANCE P ANTAGONIST ON THE SECRETION OF ALDOSTERONE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME AND ARTERIAL HYPERTENSION
PHASE2Recruiting
24 participants
Started: Mar 5, 2024 · Completed: Apr 19, 2026
1 condition1 sponsor1 location
NCT06238479
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
PHASE1Recruiting
490 participants
Started: Mar 5, 2024 · Completed: Mar 31, 2027
14 conditions1 sponsor28 locations
NCT06292104
Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)
N/ARecruiting
350 participants
Started: Mar 5, 2024 · Completed: Jan 31, 2029
1 condition2 sponsors1 location
NCT06247722
Real World Use of Tocilizumab Biosimilar studY
N/AActive, not recruiting
600 participants
Started: Mar 5, 2024 · Completed: Mar 31, 2026
1 condition1 sponsor8 locations
NCT06758453
Bile Acids As Determinants of Postprandial Metabolism
NAActive, not recruiting
150 participants
Started: Mar 5, 2024 · Completed: Dec 31, 2025
4 conditions3 sponsors1 location
NCT06732986
Does the Structure of the Tendon Relate to the Temporal, Kinetic and Kinematic Jump Variables? Athletes Vs. Non Athletes
N/AActive, not recruiting
48 participants
Started: Mar 5, 2024 · Completed: Sep 30, 2025
3 conditions1 sponsor1 location